Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Gilead Sciences
Acquired Company
Arcellx, Inc
Foster CityGaithersburgBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyDescription
Gilead Sciences, Inc. has successfully acquired Arcellx, Inc. for $7.8 billion. The acquisition closed on April 28, with Gilead paying $115 per share plus potential contingent value rights. The integration process has begun, resulting in job eliminations as Arcellx becomes part of Gilead's operations. This move highlights Gilead's strategy to enhance its pipeline in oncology.
Fundz sees it the moment Gilead Sciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Arcellx, Inc?
Arcellx, Inc was acquired by Gilead Sciences, based in Foster City. The deal was reported on October 6, 2026. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. Gilead Sciences is publicly traded (GILD) and operates in Biotechnology.
When did Gilead Sciences acquire Arcellx, Inc?
Gilead Sciences's acquisition of Arcellx, Inc was reported on October 6, 2026. Gilead Sciences, Inc. has successfully acquired Arcellx, Inc. for $7.8 billion. The acquisition closed on April 28, with Gilead paying $115 per share plus potential contingent value rights. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Arcellx, Inc do?
We are a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies. It is privately held, operating in Biotechnology, and is based in Gaithersburg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.